636 related articles for article (PubMed ID: 20966920)
21. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
22. Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
Rasha F; Ramalingam L; Menikdiwela K; Hernandez A; Moussa H; Gollahon L; Layeequr Rahman R; Moustaid-Moussa N
Exp Cell Res; 2020 Sep; 394(1):112114. PubMed ID: 32504676
[TBL] [Abstract][Full Text] [Related]
23. Role of renin-angiotensin system (RAS) in cancer.
Uemura H
Curr Cancer Drug Targets; 2011 May; 11(4):393. PubMed ID: 21395554
[No Abstract] [Full Text] [Related]
24. Physiology of local renin-angiotensin systems.
Paul M; Poyan Mehr A; Kreutz R
Physiol Rev; 2006 Jul; 86(3):747-803. PubMed ID: 16816138
[TBL] [Abstract][Full Text] [Related]
25. The renin-angiotensin system and its involvement in vascular disease.
van Thiel BS; van der Pluijm I; te Riet L; Essers J; Danser AH
Eur J Pharmacol; 2015 Sep; 763(Pt A):3-14. PubMed ID: 25987425
[TBL] [Abstract][Full Text] [Related]
26. Epochs in the depressor/pressor balance of the renin-angiotensin system.
Colafella KM; Hilliard LM; Denton KM
Clin Sci (Lond); 2016 May; 130(10):761-71. PubMed ID: 27128801
[TBL] [Abstract][Full Text] [Related]
27. The pulmonary renin-angiotensin system.
Marshall RP
Curr Pharm Des; 2003; 9(9):715-22. PubMed ID: 12570789
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
Weber MA; Giles TD
Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system revisited.
Fyhrquist F; Saijonmaa O
J Intern Med; 2008 Sep; 264(3):224-36. PubMed ID: 18793332
[TBL] [Abstract][Full Text] [Related]
30. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease.
Volpe M; Savoia C; De Paolis P; Ostrowska B; Tarasi D; Rubattu S
J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S173-8. PubMed ID: 12466309
[TBL] [Abstract][Full Text] [Related]
31. Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension.
Ciftciler R; Haznedaroglu IC
Front Endocrinol (Lausanne); 2020; 11():425. PubMed ID: 32903745
[TBL] [Abstract][Full Text] [Related]
32. Benefits of the RAS blockade: clinical evidence before the ONTARGET study.
Perret-Guillaume C; Joly L; Jankowski P; Benetos A
J Hypertens Suppl; 2009 Jun; 27(2):S3-7. PubMed ID: 19491620
[TBL] [Abstract][Full Text] [Related]
33. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
Giles TD
Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
[TBL] [Abstract][Full Text] [Related]
34. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
35. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
Weir MR
J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
[TBL] [Abstract][Full Text] [Related]
36. The renin-angiotensin system and malignancy.
Ager EI; Neo J; Christophi C
Carcinogenesis; 2008 Sep; 29(9):1675-84. PubMed ID: 18632755
[TBL] [Abstract][Full Text] [Related]
37. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
38. The renin-angiotensin system as a target of novel anticancer therapy.
Regulska K; Stanisz B; Regulski M
Curr Pharm Des; 2013; 19(40):7103-25. PubMed ID: 23859547
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the circulating and vascular renin-angiotensin system and the vasodilating effect of captopril in human hypertension.
Virdis A; Ghiadoni L; Favilla S; Duranti P; Taddei S; Salvetti A
Blood Press; 1999; 8(2):85-93. PubMed ID: 10451035
[TBL] [Abstract][Full Text] [Related]
40. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
